Nicholas Investment Partners LP Has Cut Array Biopharma (ARRY) Holding as Valuation Rose; As Masco (MAS) Stock Declined, Jpmorgan Chase & Company Has Trimmed Stake

April 20, 2018 - By Vivian Park

Array BioPharma Inc. (NASDAQ:ARRY) Logo

Nicholas Investment Partners Lp decreased its stake in Array Biopharma Inc (ARRY) by 17.95% based on its latest 2017Q4 regulatory filing with the SEC. Nicholas Investment Partners Lp sold 49,740 shares as the company’s stock rose 29.01% while stock markets declined. The institutional investor held 227,402 shares of the major pharmaceuticals company at the end of 2017Q4, valued at $2.91 million, down from 277,142 at the end of the previous reported quarter. Nicholas Investment Partners Lp who had been investing in Array Biopharma Inc for a number of months, seems to be less bullish one the $3.00 billion market cap company. The stock decreased 5.56% or $0.85 during the last trading session, reaching $14.44. About 2.90M shares traded. Array BioPharma Inc. (NASDAQ:ARRY) has risen 68.58% since April 20, 2017 and is uptrending. It has outperformed by 57.03% the S&P500.

Jpmorgan Chase & Company decreased its stake in Masco Corp (MAS) by 4.94% based on its latest 2017Q4 regulatory filing with the SEC. Jpmorgan Chase & Company sold 645,047 shares as the company’s stock declined 7.67% with the market. The institutional investor held 12.42M shares of the forest products company at the end of 2017Q4, valued at $545.73 million, down from 13.07 million at the end of the previous reported quarter. Jpmorgan Chase & Company who had been investing in Masco Corp for a number of months, seems to be less bullish one the $12.38B market cap company. The stock decreased 3.78% or $1.56 during the last trading session, reaching $39.75. About 7.20 million shares traded or 115.30% up from the average. Masco Corporation (NYSE:MAS) has risen 19.95% since April 20, 2017 and is uptrending. It has outperformed by 8.40% the S&P500.

Jpmorgan Chase & Company, which manages about $474.64 billion US Long portfolio, upped its stake in Occidental Pete Corp Del (NYSE:OXY) by 301,393 shares to 37.71 million shares, valued at $2.78 billion in 2017Q4, according to the filing. It also increased its holding in Centurylink Inc (NYSE:CTL) by 3.81M shares in the quarter, for a total of 6.16M shares, and has risen its stake in Ishares Tr (Call).

Analysts await Masco Corporation (NYSE:MAS) to report earnings on April, 24 before the open. They expect $0.49 earnings per share, up 19.51% or $0.08 from last year’s $0.41 per share. MAS’s profit will be $152.55 million for 20.28 P/E if the $0.49 EPS becomes a reality. After $0.44 actual earnings per share reported by Masco Corporation for the previous quarter, Wall Street now forecasts 11.36% EPS growth.

Among 24 analysts covering Masco (NYSE:MAS), 14 have Buy rating, 0 Sell and 10 Hold. Therefore 58% are positive. Masco had 63 analyst reports since July 28, 2015 according to SRatingsIntel. The stock of Masco Corporation (NYSE:MAS) has “Buy” rating given on Wednesday, October 25 by RBC Capital Markets. The firm has “Outperform” rating given on Friday, January 22 by Robert W. Baird. The stock of Masco Corporation (NYSE:MAS) earned “Buy” rating by Argus Research on Thursday, October 26. Longbow upgraded the stock to “Buy” rating in Thursday, April 6 report. The rating was maintained by Nomura with “Buy” on Wednesday, October 25. Raymond James downgraded the shares of MAS in report on Wednesday, October 25 to “Market Perform” rating. On Tuesday, November 14 the stock rating was maintained by RBC Capital Markets with “Buy”. The stock of Masco Corporation (NYSE:MAS) earned “Neutral” rating by M Partners on Wednesday, October 28. The company was upgraded on Monday, January 25 by Evercore. M Partners maintained the shares of MAS in report on Tuesday, July 28 with “Neutral” rating.

Since October 26, 2017, it had 0 buys, and 8 sales for $9.47 million activity. 5,592 shares were sold by LOSH J MICHAEL, worth $234,989 on Tuesday, February 27. $2.00 million worth of stock was sold by MANOOGIAN RICHARD A on Monday, March 12. 10,203 shares were sold by Gross Joseph B., worth $438,219 on Friday, February 23. The insider Sznewajs John G sold $2.09 million. 17,026 Masco Corporation (NYSE:MAS) shares with value of $682,254 were sold by Lindow John P. $241,844 worth of stock was sold by VAN LOKEREN MARY ANN on Monday, March 12.

Investors sentiment increased to 1 in Q4 2017. Its up 0.02, from 0.98 in 2017Q3. It is positive, as 26 investors sold MAS shares while 199 reduced holdings. 77 funds opened positions while 149 raised stakes. 272.45 million shares or 1.07% less from 275.40 million shares in 2017Q3 were reported. Marshall Wace Limited Liability Partnership holds 0.01% of its portfolio in Masco Corporation (NYSE:MAS) for 5,540 shares. Bamco New York holds 0.08% or 403,500 shares in its portfolio. 582,025 are owned by Royal Bank Of Canada. New Mexico Educational Retirement Board holds 30,671 shares. Morgan Stanley invested in 1.96M shares. Canandaigua Retail Bank Trust accumulated 5,183 shares or 0.04% of the stock. Oakbrook Invs Ltd Liability Corp reported 25,174 shares stake. Stone Ridge Asset Mgmt Ltd Llc stated it has 7,569 shares. 788,655 were reported by California Public Employees Retirement Systems. Dimensional Fund Advisors LP has invested 0.02% in Masco Corporation (NYSE:MAS). Chesapeake Asset holds 50,000 shares. Bb&T Ltd reported 0.01% in Masco Corporation (NYSE:MAS). Moreover, Ftb Advsrs has 0% invested in Masco Corporation (NYSE:MAS). Td Asset Mgmt Inc has 0.04% invested in Masco Corporation (NYSE:MAS). Regions Fincl Corp has 31,401 shares.

Among 10 analysts covering Array BioPharma (NASDAQ:ARRY), 9 have Buy rating, 0 Sell and 1 Hold. Therefore 90% are positive. Array BioPharma had 37 analyst reports since June 3, 2016 according to SRatingsIntel. The firm has “Buy” rating given on Wednesday, September 20 by Piper Jaffray. Piper Jaffray maintained Array BioPharma Inc. (NASDAQ:ARRY) on Wednesday, November 29 with “Buy” rating. The firm has “Buy” rating given on Wednesday, August 9 by Stifel Nicolaus. The firm has “Buy” rating by Stifel Nicolaus given on Tuesday, February 6. The stock of Array BioPharma Inc. (NASDAQ:ARRY) earned “Buy” rating by Cowen & Co on Wednesday, February 7. The firm has “Buy” rating given on Tuesday, October 31 by SunTrust. The rating was maintained by Cowen & Co with “Buy” on Tuesday, October 31. The firm earned “Buy” rating on Tuesday, May 30 by Cantor Fitzgerald. The rating was maintained by Piper Jaffray with “Buy” on Wednesday, May 31. The firm has “Neutral” rating by JP Morgan given on Friday, February 3.

Nicholas Investment Partners Lp, which manages about $1.37 billion and $1.52B US Long portfolio, upped its stake in Hilton Grand Vacations Inc by 9,611 shares to 110,788 shares, valued at $4.65 million in 2017Q4, according to the filing. It also increased its holding in Home Depot Inc (NYSE:HD) by 7,991 shares in the quarter, for a total of 23,874 shares, and has risen its stake in Crane Co (NYSE:CR).

Investors sentiment increased to 1.3 in 2017 Q4. Its up 0.09, from 1.21 in 2017Q3. It improved, as 20 investors sold ARRY shares while 50 reduced holdings. 27 funds opened positions while 64 raised stakes. 194.11 million shares or 1.73% more from 190.80 million shares in 2017Q3 were reported. Pnc Finance Svcs has invested 0% in Array BioPharma Inc. (NASDAQ:ARRY). Shell Asset Management holds 0.01% or 21,781 shares. Venbio Select Advisor Ltd has invested 4.54% in Array BioPharma Inc. (NASDAQ:ARRY). Janney Montgomery Scott Ltd Liability Corp stated it has 0% in Array BioPharma Inc. (NASDAQ:ARRY). Rhenman Ptnrs Asset holds 503,059 shares or 0.87% of its portfolio. Quantitative Systematic Strategies Ltd Liability Corporation reported 13,238 shares stake. 95,725 were accumulated by Neuberger Berman Limited Liability. 683 Cap Mngmt Limited Liability holds 0.49% or 450,000 shares in its portfolio. Renaissance Tech Limited has 712,671 shares. Manufacturers Life Insurance Commerce The has invested 0% of its portfolio in Array BioPharma Inc. (NASDAQ:ARRY). Endurant Capital LP reported 50,600 shares or 0.2% of all its holdings. Hanseatic Management Inc has invested 0% in Array BioPharma Inc. (NASDAQ:ARRY). Vanguard Group has 21.72 million shares for 0.01% of their portfolio. Principal Finance Grp Incorporated accumulated 362,132 shares. Susquehanna Group Inc Limited Liability Partnership holds 0% in Array BioPharma Inc. (NASDAQ:ARRY) or 520,780 shares.

Analysts await Array BioPharma Inc. (NASDAQ:ARRY) to report earnings on May, 9. They expect $-0.22 EPS, down 4.76% or $0.01 from last year’s $-0.21 per share. After $-0.17 actual EPS reported by Array BioPharma Inc. for the previous quarter, Wall Street now forecasts 29.41% negative EPS growth.

Masco Corporation (NYSE:MAS) Institutional Positions Chart

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>